Reducing inequity of cataract blindness and vision impairment is a global priority, but where is the evidence?

The British Journal of Ophthalmology
Jacqueline RamkeClare E Gilbert

Abstract

Throughout the world, people who are socially or economically disadvantaged disproportionately experience blindness and vision impairment caused by cataract. Reducing vision loss from cataract and its unequal distribution must be a priority if the WHO's aim of 'universal eye health' is to be realised. To help achieve this, decision-makers and service planners need evidence on which strategies improve access to cataract services among disadvantaged populations, and under what circumstances. Unfortunately, despite many strategies to improve cataract services being implemented in recent decades, evidence of what works, for who and in what circumstances is not readily available. This paper summarises the extent of the evidence on interventions to reduce inequity of vision loss from cataract and makes suggestions for how the evidence base can be strengthened.

References

Jan 1, 1992·International Journal of Health Services : Planning, Administration, Evaluation·M Whitehead
Jul 31, 2013·Paediatric Respiratory Reviews·Christopher H Goss, Nathan Tefft
Nov 22, 2013·BMJ : British Medical Journal·David H PetersNhan Tran
Nov 29, 2013·BMJ : British Medical Journal·Michael PetersAmber L Ryan
Dec 10, 2013·Global Health Action·Helia GhaneanLars Jacobsson
Jan 5, 2014·BMC Health Services Research·Kathryn OliverJames Thomas
Apr 19, 2015·Health Policy and Planning·Bradley H WagenaarAlexander C Wagenaar
Aug 12, 2016·Lancet·Noah M Ivers, Jeremy M Grimshaw
Dec 13, 2016·International Journal for Equity in Health·Kumanan Rasanathan, Theresa Diaz
Feb 24, 2017·The British Journal of Ophthalmology·Jacqueline RamkeClare E Gilbert
Apr 4, 2017·Journal of Clinical Epidemiology·Till BärnighausenSebastian Vollmer
Apr 4, 2017·Journal of Clinical Epidemiology·Pascal Geldsetzer, Wafaie Fawzi
Apr 10, 2017·Journal of Clinical Epidemiology·Peter C RockersTill Bärnighausen
Sep 25, 2017·Middle East African Journal of Ophthalmology·Jacqueline RamkeClare E Gilbert
Oct 17, 2017·The Lancet Global Health·Seth R FlaxmanUNKNOWN Vision Loss Expert Group of the Global Burden of Disease Study
Oct 17, 2017·The Lancet Global Health·Charumathi Sabanayagam, Ching-Yu Cheng

❮ Previous
Next ❯

Citations

Feb 21, 2019·Eye·Jennifer EvansUNKNOWN Cochrane Eyes and Vision
Aug 4, 2020·Clinical & Experimental Ophthalmology·João M Furtado
Nov 21, 2018·Bulletin of the World Health Organization·Jacqueline RamkeClare E Gilbert
Aug 14, 2020·Diagnostics·Hiroyuki YazuHiroshi Fujishima
Feb 20, 2021·The Lancet Global Health·Matthew J BurtonHannah B Faal
Jul 23, 2021·Clinical & Experimental Ophthalmology·Miho YoshizakiJohn Buchan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Canadian Medical Association Journal
J M Last
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
Jill M StarkesStephen R Kisely
© 2022 Meta ULC. All rights reserved